As­traZeneca de­buts first con­sumer cam­paign for its Covid-19 pro­phy­lac­tic Evusheld — and a first for EUA drugs

As­traZeneca’s first con­sumer ad for Evusheld is al­so a first for drugs that have been grant­ed emer­gency use au­tho­riza­tions dur­ing the pan­dem­ic.

The first DTC ad for a med­i­cine un­der emer­gency ap­proval, the Evusheld cam­paign launch­ing this week aims to raise aware­ness among im­muno­com­pro­mised pa­tients — and spur more use.

Evusheld nabbed emer­gency au­tho­riza­tion in De­cem­ber, how­ev­er, de­spite mil­lions of im­muno­com­pro­mised peo­ple look­ing for a so­lu­tion and now more wide­spread avail­abil­i­ty of the drug.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER